Skip to main content
NCBI home page
The American Journal of Pathology logoLink to The American Journal of Pathology
. 1975 Nov;81(2):389–400.

Inflammatory mediators in culture filtrates of Escherichia coli.

T Yoshida, S Cohen, P E Bigazzi, T Kurasuji, A Amsden
PMCID: PMC2032210  PMID: 1103632

Abstract

Escherichia coli, when cultured on a simple medium containing only glucose and inorganic compounds, release soluble factors which have a variety of biologic effects on cells in vitro. These low molecular weight (less than 12,000) substances are capable of: a) reversibly inhibiting the migration of macrophages, b) causing chemotactic attraction of neutrophils, c) inducing blast transformation of lymphocytes, and d) producing cytotoxic effects on mouse fibroblasts in culture. Although these activities are functionally similar to those which have been described for various lymphokines obtained from antigen-activated lymphocyte cultures, lymphocyte and bacterial factors which share a given property do not appear to be identical. For example, the bacterial factor which inhibits macrophage migration is partially heat labile and is dialyzable, characteristics which distinguish it from conventional migration inhibition factor. Nevertheless, similarity of function may imply the existence of some degree of chemical homology which would have importance implications concerning the evolution of host-defense reactions. In any case, as is the situation for the lymphokines, the in vitro behavior of the bacterial factors suggest a role for them in in vivo inflammatory responses.

Full text

PDF
389

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bigazzi P. E., Yoshida T., Ward P. A., Cohen S. Production of lymphokine-like factors (cytokines) by simian virus 40-infected and simian virus 40-transformed cells. Am J Pathol. 1975 Jul;80(1):69–78. [PMC free article] [PubMed] [Google Scholar]
  2. David J. R., David R. R. Cellular hypersensitivity and immunity. Inhibition of macrophage migration and the lymphocyte mediators. Prog Allergy. 1972;16:300–449. [PubMed] [Google Scholar]
  3. Epstein L. B., Kreth H. W., Herzenberg L. A. Fluorescence-activated cell sorting of human T and B lymphocytes. II. Identification of the cell type responsible for interferon production and cell proliferation in response to mitogens. Cell Immunol. 1974 Jun;12(3):407–421. doi: 10.1016/0008-8749(74)90097-5. [DOI] [PubMed] [Google Scholar]
  4. Flanagan T. D., Yoshida T., Cohen S. Production of macrophage migration inhibition factors by virus-infected cell cultures. Infect Immun. 1973 Aug;8(2):145–150. doi: 10.1128/iai.8.2.145-150.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Granger G. A., Kolb W. P. Lymphocyte in vitro cytotoxicity: mechanisms of immune and non-immune small lymphocyte mediated target L cell destruction. J Immunol. 1968 Jul;101(1):111–120. [PubMed] [Google Scholar]
  6. Heilman D. H., Bast R. C., Jr In vitro assay of endotoxin by the inhibition of macrophage migration. J Bacteriol. 1967 Jan;93(1):15–20. doi: 10.1128/jb.93.1.15-20.1967. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Heymer B., Bültmann B., Schachenmayr W., Spanel R., Haferkamp O., Schmidt W. C. Migration inhibition of rat peritoneal cells induced by streptococcal mucopeptides. Characteristics of the reaction and properties of the mucopeptide preparations. J Immunol. 1973 Dec;111(6):1743–1754. [PubMed] [Google Scholar]
  8. Papageorgiou P. S., Henley W. L., Glade P. R. Production and characterization of migration inhibitory factor(s) (MIF) of established lymphoid and non-lymphoid cell lines. J Immunol. 1972 Feb;108(2):494–504. [PubMed] [Google Scholar]
  9. Reeves J., Yoshida T., Cohen S. Quantitative aspects of the migration inhibition reaction. Immunol Commun. 1973;2(3):287–296. doi: 10.3109/08820137309022800. [DOI] [PubMed] [Google Scholar]
  10. Rocklin R. E., MacDermott R. P., Chess L., Schlossman S. F., David J. R. Studies on mediator production by highly purified human T and B lymphocytes. J Exp Med. 1974 Nov 1;140(5):1303–1316. doi: 10.1084/jem.140.5.1303. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Rotta J., Bednár B. Biological properties of cell wall mucopeptide of hemolytic streptococci. J Exp Med. 1969 Jul 1;130(1):31–47. doi: 10.1084/jem.130.1.31. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Seravalli E., Taranta A. Lymphocyte transformation and macrophage migration inhibition by electrofocused and gel-filtered fractions of group A streptococcal filtrate. Cell Immunol. 1974 Dec;14(3):366–375. doi: 10.1016/0008-8749(74)90186-5. [DOI] [PubMed] [Google Scholar]
  13. Tubergen D. G., Feldman J. D., Pollock E. M., Lerner R. A. Production of macrophage migration inhibition factor by continuous cell lines. J Exp Med. 1972 Feb 1;135(2):255–266. doi: 10.1084/jem.135.2.255. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. WARD P. A., COCHRANE C. G., MUELLER-EBERHARD H. J. THE ROLE OF SERUM COMPLEMENT IN CHEMOTAXIS OF LEUKOCYTES IN VITRO. J Exp Med. 1965 Aug 1;122:327–346. doi: 10.1084/jem.122.2.327. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Wahl S. M., Iverson G. M., Oppenheim J. J. Induction of guinea pig B-cell lymphokine synthesis by mitogenic and nonmitogenic signals to Fc, Ig, and C3 receptors. J Exp Med. 1974 Dec 1;140(6):1631–1645. doi: 10.1084/jem.140.6.1631. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Ward P. A., Cohen S., Flanagan T. D. Leukotactic factors elaborated by virus-infected tissues. J Exp Med. 1972 May 1;135(5):1095–1103. doi: 10.1084/jem.135.5.1095. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Ward P. A., Lepow I. H., Newman L. J. Bacterial factors chemotactic for polymorphonuclear leukocytes. Am J Pathol. 1968 Apr;52(4):725–736. [PMC free article] [PubMed] [Google Scholar]
  18. Yoshida T., Bigazzi P., Cohen S. Biologic and antigenic similarity of virus-induced migration inhibition factor to conventional, lymphocyte-derived migration inhibition factor. Proc Natl Acad Sci U S A. 1975 Apr;72(4):1641–1644. doi: 10.1073/pnas.72.4.1641. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Yoshida T., Cohen S. Lymphokine activity in vivo in relation to circulating monocyte levels and delayed skin reactivity. J Immunol. 1974 Apr;112(4):1540–1547. [PubMed] [Google Scholar]
  20. Yoshida T., Janeway C. A., Jr, Paul W. E. Activity of migration inhibitory factor in the absence of antigen. J Immunol. 1972 Aug;109(2):201–206. [PubMed] [Google Scholar]
  21. Yoshida T., Reisfeld R. A. Two fractions with macrophage migration inhibitory activity from sensitized lymphocyte cultures. Nature. 1970 May 30;226(5248):856–857. doi: 10.1038/226856a0. [DOI] [PubMed] [Google Scholar]
  22. Yoshida T., Sonozaki H., Cohen S. The production of migration inhibition factor by B and T cells of the guinea pig. J Exp Med. 1973 Oct 1;138(4):784–797. doi: 10.1084/jem.138.4.784. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from The American Journal of Pathology are provided here courtesy of American Society for Investigative Pathology

RESOURCES